These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2137666)

  • 21. Evaluation of the safety and efficacy of isradipine in elderly patients with essential hypertension. The British Isradipine Hypertension Group.
    Am J Med; 1989 Apr; 86(4A):110-4. PubMed ID: 2523644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
    Lacourcière Y; Asmar R
    Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Slow-release isradipine in mild to moderate hypertension: hemodynamic and antihypertensive effects.
    Celentano A; Galderisi M; Tammaro P; Mureddu GF; Garofalo M; de Simone G; de Divitiis O
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):494-8. PubMed ID: 1839903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter evaluation of the safety and efficacy of isradipine in hypertension. The Italian-Belgian Isradipine Study Group.
    Am J Med; 1989 Apr; 86(4A):94-7. PubMed ID: 2523664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive effect of once daily sustained release isradipine: a placebo controlled cross-over study.
    Arzilli F; Gandolfi E; Del Prato C; Innocenti P; Ponzanelli F; Caiazza A; Ghisoni F; Saba P; Giuntoli F; Borgnino C
    Eur J Clin Pharmacol; 1993; 44(1):23-5. PubMed ID: 8436150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ambulatory blood pressure response to once-daily fimasartan: an 8-week, multicenter, randomized, double-blind, active-comparator, parallel-group study in Korean patients with mild to moderate essential hypertension.
    Lee H; Kim KS; Chae SC; Jeong MH; Kim DS; Oh BH
    Clin Ther; 2013 Sep; 35(9):1337-49. PubMed ID: 23932463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension. Isradipine in Hypertension Study Group.
    Am J Med; 1989 Apr; 86(4A):119-23. PubMed ID: 2523646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crossover comparison of atenolol, enalapril, hydrochlorothiazide and isradipine for isolated systolic systemic hypertension.
    Silagy CA; McNeil JJ; McGrath BP
    Am J Cardiol; 1992 Nov; 70(15):1299-305. PubMed ID: 1442581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of antihypertensive effects of once-a-day isradipine and fosinopril: a double-blind crossover study by means of ambulatory blood pressure monitoring.
    Perticone F; Pugliese F; Marcantonio AM; Cloro C; Maio R; Mattioli PL
    Clin Cardiol; 1995 Jul; 18(7):401-7. PubMed ID: 7554545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure.
    Portaluppi F; Vergnani L; Manfredini R; degli Uberti EC; Fersini C
    Am J Hypertens; 1995 Jul; 8(7):719-26. PubMed ID: 7546498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Additive effect of isradipine in combination with captopril in hypertensive patients.
    Eggertsen R; Svensson A; Dahlöf B; Hansson L
    Am J Med; 1989 Apr; 86(4A):124-6. PubMed ID: 2523647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
    de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M
    Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive effect of isradipine on ambulatory and casual blood pressure.
    Fitscha P; Meisner W
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):67S-69S. PubMed ID: 8466731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicentre isradipine dose-confirmation study in Thai patients with hypertension.
    Tanomsup S; Tantbirojn P; Koanantakul B; Nontakanun S; Jaroonvesama N; Charoenlarp K
    Drugs; 1990; 40 Suppl 2():22-5. PubMed ID: 2150635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and tolerability of once-daily oral fimasartan 20 to 240 mg/d in Korean Patients with hypertension: findings from Two Phase II, randomized, double-blind, placebo-controlled studies.
    Lee H; Yang HM; Lee HY; Kim JJ; Choi DJ; Seung KB; Jeon ES; Ha JW; Rim SJ; Park JB; Shin JH; Oh BH
    Clin Ther; 2012 Jun; 34(6):1273-89. PubMed ID: 22608107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intra-arterial monitoring of the antihypertensive effects of once-daily amlodipine.
    Broadhurst P; Heber ME; Brigden G; al-Khawaja I; Raftery EB
    J Hum Hypertens; 1992 Dec; 6 Suppl 1():S9-12. PubMed ID: 1293307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of blood pressure rhythms for drug efficacy evaluation.
    Germanò G; Federico L; Angotti S; Codispoti P; Muscolo M; Bravo S; Damiani S
    Ann N Y Acad Sci; 1996 Aug; 783():254-62. PubMed ID: 8853647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of perioperative hypertension using intravenous isradipine.
    Rüegg PC; Karmann U; Keller H
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):203S-206S. PubMed ID: 1827023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium antagonists as first-line antihypertensive agents: a placebo-controlled, comparative trial of isradipine and nifedipine.
    Welzel D; Burger KJ; Weidinger G
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S70-4. PubMed ID: 1695308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.